Imatinib mesylate

Imatinib · Mylan Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

117 regulatory and trial events tracked for Imatinib mesylate, covering 2007-04-27 to 2026-04-06. Get the full timeline:

Most recent: FDA Approved: IMATINIB MESYLATE — Supplemental Application (BluePoint Laboratories)